Walleye Capital’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Walleye Capital's UTHR Position: Q3 2026 in Review
Walleye Capital opened a new position in United Therapeutics (UTHR) in Q3 2026: 4,053 shares worth $2.2M. The stake represents ﹤0.01% of the portfolio and ranks #2724 among its holdings. This is a return to the name: Walleye Capital previously reported a position in UTHR as recently as Q1 2026.
Walleye Capital first reported a position in UTHR in Q1 2019 and has held it in 21 quarters since. The position peaked at $13M in Q3 2022. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Walleye Capital held 4,053 shares of United Therapeutics worth $2.2M as of Q3 2026.
- United Therapeutics was a new Walleye Capital position in Q3 2026.
- United Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2724 holding.
- Walleye Capital first reported a position in United Therapeutics in Q1 2019 and has held it in 21 quarters since.
- Walleye Capital's United Therapeutics position peaked at $13M in Q3 2022.
- 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.